Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD

被引:4
|
作者
Alizadeh, Madeline [1 ,2 ]
Motwani, Kiran [2 ]
Siaton, Bernadette C. [3 ]
Abutaleb, Ameer [4 ]
Ravel, Jacques [1 ]
Cross, Raymond K. [2 ]
机构
[1] Univ Maryland, Inst Genome Sci, Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, Baltimore, MD USA
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Surg, Washington, DC USA
关键词
inflammatory bowel disease; extraintestinal manifestations; SPARC; CLINICAL-FEATURES; RISK-FACTORS;
D O I
10.1093/ibd/izad280
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD, yet predicting who may develop them is difficult. The goal of our study was to better characterize which patients may be at highest risk of developing not only 1 EIM, but also multiple EIMs, across both diseases.Methods A retrospective study of participants enrolled in the SPARC IBD (Study of Prospective Adult Research Cohort with IBD) registry was performed, and demographic and clinical data were analyzed. A total of 1211 patients with data available on EIMs were included, and differences among variables with vs without EIMs were assessed.Results A total of 329 participants with at least 1 EIM were identified, compared with 882 participants without any EIMs. Crohn's disease patients and women were more likely to have 2 or more EIMs (P = .005 and P <= .001, respectively). Participants with ocular manifestations were likeliest to have at least 2 EIMs (P <= .001). Even when diagnosis was controlled for, involvement of the right colon (P = .021) was predictive of IBD-associated arthritis across both diseases in a multivariate generalized linear model.Conclusions This is the first comprehensive large-cohort assessment of how EIMs relate to one another at the individual vs systems levels. Further, our analysis is the first to recognize specific locations of colon involvement associated with EIMs of IBD, regardless of IBD type. These results are important in identifying patients at risk of developing future EIMs and may help with risk stratification when choosing treatments. Although extraintestinal manifestations frequently complicate inflammatory bowel disease, predicting those at highest risk of developing them is difficult. We found female patients with Crohn's disease, ocular, and dermatologic manifestations are likeliest to develop multiple extraintestinal manifestations. Further, we found right-sided involvement is predictive of inflammatory bowel disease-associated arthritis.
引用
收藏
页码:2027 / 2036
页数:10
相关论文
共 50 条
  • [31] Extraintestinal manifestations of inflammatory bowel disease.
    Bernstein C.N.
    Current Gastroenterology Reports, 2001, 3 (6) : 477 - 483
  • [32] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (03) : 333 - 347
  • [33] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [34] Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
    Alizadeh, Madeline
    Ali, Osman
    Cross, Raymond K.
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [35] Extraintestinal Manifestations Are Associated With Disease Severity in Pediatric Onset Inflammatory Bowel Disease
    Jansson, Sabine
    Malham, Mikkel
    Paerregaard, Anders
    Jakobsen, Christian
    Wewer, Vibeke
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (01): : 40 - 45
  • [36] Extraintestinal Manifestations in Inflammatory Bowel Disease. Are They Associated with More Severe Disease?
    Castro, Javier A.
    Lorenzo, Aurelio
    Pereira, Santos
    Carpio, Daniel
    Echarri, Ana
    Barreiro, Manuel
    GASTROENTEROLOGY, 2009, 136 (05) : A363 - A363
  • [37] Characterisation of Extraintestinal Manifestations in Inflammatory Bowel Disease, and Chronology of Extraintestinal relative to Intestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
    Vavricka, Stephan R.
    Rogler, Gerhard
    Gantenbein, Claudine
    Spoerri, Muriel
    Vavricka, Mareike Prinz
    Navarini, Alexander A.
    French, Lars
    Safroneeva, Ekaterina
    Fournier, Nicolas
    Straumann, Alex
    Froehlich, Florian
    Fried, Michael
    Michetti, Pierre
    Schoepfer, Alain M.
    SWISS MEDICAL WEEKLY, 2013, 143 : 14S - 14S
  • [38] Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort
    Vavricka, Stephan R.
    Brun, Lionel
    Ballabeni, Pierluigi
    Pittet, Valerie
    Vavricka, Bettina Mareike Prinz
    Zeitz, Jonas
    Rogler, Gerhard
    Schoepfer, Alain M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01): : 110 - 119
  • [39] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 1697 - 1697
  • [40] Diagnosis and Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease
    Gupta, Abhinav
    Choi, Sarah
    SURGICAL CLINICS OF NORTH AMERICA, 2025, 105 (02) : 385 - 404